1Y Annualised Return
▼-15.56%
3Y Annualised Return
▲22.48%
5Y Annualised Return
▲25.97%
|
|
|
As of 11 Jul, 2025, Lincoln Pharmaceuticals share price is ₹549.8. The stock opened at ₹557 and had closed at ₹557 the previous day. During today’s trading session, Lincoln Pharmaceuticals share price moved between ₹548.65 and ₹560.95, with an average price for the day of ₹554.80. Over the last 52 weeks, the stock has recorded a low of ₹499.00 and a high of ₹979.50. In terms of performance, Lincoln Pharmaceuticals share price has declined by 31.6% over the past six months and has declined by 15.56% over the last year.
Over the past
Market Cap (in crs)
1,101.33
Face Value
10
Turnover (in lacs)
223.13
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
168.18 Cr | 146.55 Cr | 161.21 Cr | 147.28 Cr | 142.49 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
645.71 Cr | 614.97 Cr | 532.78 Cr | 482.12 Cr | 429.85 Cr | 397.53 Cr |
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
11.58 Cr | 20.77 Cr | 26.33 Cr | 23.67 Cr | 18.6 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
82.35 Cr | 93.3 Cr | 72.9 Cr | 69.36 Cr | 62.25 Cr | 51.47 Cr |
Lincoln Pharmaceuticals Ltd reported a 3.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 28.5%.
Its expenses for the quarter were up by 0.4% QoQ and 28.1% YoY.
The net profit decreased 10.4% QoQ and increased 48.1% YoY.
The earnings per share (EPS) of Lincoln Pharmaceuticals Ltd stood at 9.3 during Q4FY25.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 29685 Rs | 45138 Rs |
Week Rs | 26580 Rs | 54982 Rs |
Month Rs | 26004 Rs | 52816 Rs |
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123.40 | 1,139.64 | 115 | 317 | 123.89 | -0.86% | -15.57% | -52.50% | -46.03% | 53.11% | 0.00% | 47.75 | 42.82 | 3.98 | |
204.72 | 1,031.91 | 148.5 | 245.7 | 208.80 | -4.45% | -4.88% | -3.60% | 0.00% | 0.00% | 0.73% | 21.79 | 42.82 | 3.16 | |
382.00 | 1,131.47 | 194 | 449 | 374.05 | 16.96% | 14.73% | -4.53% | 88.78% | 103.63% | 0.00% | 16.74 | 42.82 | 2.98 | |
1,231.45 | 483.1 | 1235 | 1,167.55 | 0.84% | 19.23% | 22.30% | 137.67% | 295.60% | 0.00% | 30.87 | 42.82 | 4.65 | ||
983.83 | 802 | 1870 | 1,410.90 | 13.82% | 12.60% | 1.49% | -9.65% | 332.58% | 0.07% | 37.19 | 42.82 | 2.54 | ||
Remus Pharmaceuticals Ltd. | 930.70 | 930.70 | - | - | - | - | - | - | - | - | - | - | - | - |
Lincoln Pharmaceuticals share price is ₹549 in NSE and ₹552 in BSE as on 11/7/2025.
Lincoln Pharmaceuticals share price in the past 1-year return was -16.63. The Lincoln Pharmaceuticals share hit a 1-year low of Rs. 499 and a 1-year high of Rs. 979.5.
The market cap of Lincoln Pharmaceuticals is Rs. 1101.33 Cr. as of 11/7/2025.
The PE ratios of Lincoln Pharmaceuticals is 13.38 as of 11/7/2025.
The PB ratios of Lincoln Pharmaceuticals is 1.64 as of 11/7/2025
You can easily buy Lincoln Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Lincoln Pharmaceuticals share price is ₹979.5 and ₹499 as of 11/7/2025.
Please be aware that Lincoln Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.